CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $341.3M
Liabilities Breakdown FY2019
Total Liabilities: $290.2M
Asset Breakdown
Total Assets: $341.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $188.4M | 55.2% |
| Accounts Receivable | $13.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.4M | 2.2% |
| Goodwill | $949.0K | 0.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $144.5M | 42.3% |
Liabilities Breakdown
Total Liabilities: $290.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.2M | 1.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $286.0M | 98.6% |